100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
VTE pharmacology $8.49   Add to cart

Other

VTE pharmacology

 4 views  0 purchase

This document is a summary of pharmacology related to venous thromboembolism (VTE) including - definition of VTE - diagram of normal blood coagulation cascade - prophylaxis of VTE - treatment of VTE - regimens for anticoagulant medications including bridge and overlap therapy - VTE treatme...

[Show more]

Preview 1 out of 1  pages

  • August 5, 2024
  • 1
  • 2023/2024
  • Other
  • Unknown
All documents for this subject (1)
avatar-seller
chris47
Venous Thromboembolism·
Venous thromboembolism (VTE) is an umbrella term for two types of clots. A deep vein thrombosis (DVT) is a clot Vessels have a layer of collagen


·
that forms in deep veins, and a pulmonary embolism (PE) is a clot in the lungs. and tissue factor (TF) around
them that maintains a balance
between clotting and bleeding.
Normal blood clotting is shown on the right. Regulation mechanisms include: ⑪ It’s separated from circulating
• A complex of Protein C and S, which inactivate factors 5 (V) and 8 (VIII) coagulation factors by
• Antithrombin, which inactivates factor 10 (X) and thrombin (Factor 2 (II)) epithelium.
• Heparan Sulfate, which upregulates antithrombin When the epithelium is
• tissue factor pathway inhibitor, which inhibits tissue factor. damaged during vessel




&
injury, that layer of tissue
factor and collagen becomes
Plasmin is a protein that breaks fibrin down, weakening the fibrin mesh and causing the clot to break down. As a exposed to circulating
byproduct, fibrin will release D-Dimer. D-Dimer is a good lab to run to RULE OUT VTE, not diagnose. If levels of D- coagulation factors,
Dimer are low, venous thromboembolism is unlikely. initiating the process to form
a blood clot.
Risk factors for VTE are known as Virchow’s Triad:
• Blood Stasis Tissue factors combines. With
• Hypercoaguable disorders activated Factor 7 (VII) to
• Blood vessel injury
m - 11
Extrinsic
Tenase
form extrinsic Tenase.
Extrinsic Tenase activates
factors 9 (IX) and 10 (X).


Prevention Special populations
LMWH or May use IPC LMWH and UFH are preferred
=m
Medically ill Pregnant
fondaparinux instead of meds and don’t pass the placenta

LMWH and Warfarin are Factor 10 (X). Combines with
Stockings or
TKA/THA DOAC or ASA Pediatric activated factor 5 (V) to form a
IPC w/ meds preferred Prothrombinase prothrombinase complex.


Emma
Remember, an ending of -ase
Hip fracture Stockings or LMWH monotherapy: Dalteparin 200U/Kg indicates an enzyme. In this
LMWH or Cancer q24hr for 30 days, followed by 150U/Kg Prothrombin
IPC w/ meds case, prothrombinase
Repair UFH q24hr or weight based enoxaparin dosing. enzymatically cuts
prothrombin to form thrombin,
Other LWMH or Stockings or Kidney UFH or Warfarin due to lack also known as activated factor
surgery UFH IPC w/ meds impairment of renal adjusments 2 (II).


• compression stockings are used to help promote • VTE prophylaxis should be used post-partem for *
Thrombin
venous blood flow to prevent blood stasis after at least 6 weeks following delivery.
surgery • cancer increases the risk of VTE occurrence,
• IPC is a series of cuffs wrapped around a patient’s therefore VTE prophylaxis in cancer patients
legs that inflate to compress their legs and promote should continue as long as cancer is “active” or Thrombin (Factor 2 (II)) will
activate factors 5 (V) and 8
venous blood flow every 1-2 minutes. These should chemotherapeutic drugs are being used.




*
Thrombin (VIII).
be worn for at least 18 hours per day. • Cancer patients may switch to warfarin or a
• Prevention in medically ill patients is short term to DOAC after 3-6 months of using a LMWH.
reduce the risk of bleeding due to anticoagulants • DOACs can also be used in kidney impairment if
• Prevention in surgery patients is long term and renally adjusted
should be initiated within 6-12 hours of surgery and
for at least 10 days, and up to 42 days. -
• If able to, encourage patients to walk.
• Rivaroxaban can also be used in medical patients if Factor 8 (VIII) combines
an alternative is needed. Intrinsic Tenase with factor 9 (IX) from
before to form intrinsic


Anticoagulant Dosing - Tenase, which will active
more factor 10 (X).


Now that we have a lot
Binds to antithrombin and enhances its Prothrombinase more factor 10 (X) thanks
Heparin to the previous step, a lot
inhibitory affects on coagulation cascade

Emma
more can combine with
Prothrombin factor 5 (V) to form more
LMWH Heparins that selectively inhibit factor Xa prothrombinase, which
Fondaparinux will enzymatically cut
more prothrombin, which
will form more thrombin
Inhibits VKORC1, an epoxidase that is
*
(Factor 2 (II)).
Warfarin necessary to recycle vitamin K to
activate factors II, VII, IX, and X

Dabigatran Directly inhibit thrombin, therefore Thrombin enzymatically
will cut fibrinogen to form

*
Argatroban fibrinogen is not cleaved to make fibrin, which is the protein
Bivalriudin fibirn that forms a meshwork
over a clot and stabilizes
Thrombin Fibrinogen the clot.
Factor Xa Inhibit factor Xa, therefore
Inhibitors prothrombinase is not generated
·
• caution taking DOACs and PgP inducers/inhibitors Fibrin
• Caution with rivaroxaban and apixaban with CYP3A4 inhibitors/inducers.
• Take rivaroxaban with food to improve absorption Once the site of vessel injury
• Andaxanet is a reversal agent for factor Xa inhibitors has been plugged by a blood




#
• Protamine is a reversal agent for UFH and LMWH clot, the barrier of tissue
factor and collagen is NO
• Vitamin K is a reversal agent for Warfarin LONGER in contact with
• Discontinue DOACs 2 days before surgery to restore hemostasis circulating coagulation
• Discontinue warfarin 5 days before surgery to restore hemostasis factors. Therefore, no more
• First episode of VTE with a provokable cause is treated for 3 months blood should be clotting, as
well as no bleeding should be
• Second episode of VTE or a VTE of unprovoked cause is treated for more than 3 months occurring.
• Treat VTE only if CONFIRMED. Avoid treatment if only suspected due to the risk of bleeding with
anticoagulant agents. A D-dimer level of greater than 4 is an indication to perform imaging for a VTE.
• Enoxaparin dosing is 1 mg/kg BID or 1.5 mg/kg once daily
• Fondaparinux dosing is 5 mg daily if < 50 kg, 7.5 mg daily if 50-100 kg, and 10 mg daily if > 100 kg.

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller chris47. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67096 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.49
  • (0)
  Add to cart